WHO ICTRP trial
Oral Labetalol Versus Oral Nifedipine for Controlling Hypertension in Postnatal…
PACTR202503593160636 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202503593160636 |
|---|---|
| Public title | Oral Labetalol Versus Oral Nifedipine for Controlling Hypertension in Postnatal Women in Enugu: A Multi-centre Randomised Controlled Study |
| Scientific title | Oral Labetalol Versus Oral Nifedipine for Controlling Hypertension in Postnatal Women in Enugu: A Multi-centre Randomised Controlled Study |
| Primary sponsor | self |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Nigeria;Nigeria |
| Conditions | Circulatory System Pregnancy and Childbirth Cardiology;Circulatory System;Pregnancy and Childbirth;Cardiology |
| Interventions | oral administration of labetalol ;Oral administration of Nifedipine |
| Registration date | Mar 31, 2025 |
| Target size | 50 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: